THE EFFECT OF THE ONE-CHAIN TO 2-CHAIN CONVERSION IN TISSUE PLASMINOGEN-ACTIVATOR - CHARACTERIZATION OF MUTATIONS AT POSITION-275

被引:19
作者
HIGGINS, DL
LAMB, MC
YOUNG, SL
POWERS, DB
ANDERSON, S
机构
[1] Department of Cardiovascular Research, Genentech, Inc., South San Francisco, CA 94080
关键词
Fibrinolysis; Protein Engineering; Tissue Plasminogen Activator;
D O I
10.1016/0049-3848(90)90070-S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue plasminogen activator (t-PA) is homologous to other serine proteases and contains an apparent activation cleavage site at arginine 275. It has been demonstrated that this arginine-275 can be replaced with either glutamic acid (Tate, K. M., Higgins, D. L., Holmes, W. E., Winkler, M. E., Heyneker, H. L., and Vehar, G. A. Biochemistry 26, 338-343, 1987) or glycine (Peterson, L. C., Johannessen, M., Foster, D., Kumar, A., and Mulvihill, E. Biochim. Biophys. Acta 952, 245-254, 1988; Boose, J. A., Kuismanen, E., Gerard, R., Sambrook, J. and Gething, M.-J. Biochemistry 28, 635-643, 1989) so that the product of the plasminogen activation reaction, plasmin, can no longer hydrolyze the one-chain form of t-PA to the two-chain form. These "one-chain" t-PA variants had diminished activity, compared to wild-type t-PA, in the absence of a cofactor, but in the presence of the fibrin(ogen) cofactor the two variants had activity similar to wild-type t-PA. In order to compare the effects of all possible substitutions, t-PA variants with each of the other nineteen amino acids besides arginine at position 275 were produced by site-directed mutagenesis. All were recovered from cell culture supernatants completely in the one-chain form, except for R275 (wild-type) and R275K, which were partially converted to the two-chain form. These latter two species could be completely converted to the two-chain form by plasmin. In addition, these two forms showed significantly more plasminogen activating activity in the absence of a fibrin(ogen) cofactor, compared to the other 18 variants. In the presence of a cofactor, all of the t-PA mutants had plasminogen activating activity equivalent to wild-type t-PA, except for R275C. The R275C t-PA had comparatively less clot lysis and fibrin binding activity as well. Presumably the new cysteine in this variant was involved in a mixed disulfide or caused misfolding of the molecule resulting in decreased activity. The difference in the plasminogen activating activity of one- and two-chain forms of t-PA was investigated by determining the apparent Michaelis constants and the apparent turnover numbers for R275E t-PA, which remains in the one-chain form throughout the assay, and two-chain R275 t-PA. The kinetic constants were measured in both the presence and the absence of plasmin-digested fibrinogen. It was found that the decrease in the ability of the one-chain variants compared to the two-chain variants to convert plasminogen to plasmin in the absence of a cofactor was due primarily to a difference in kcat, which was lower by approximately 10-fold. In the presence of a fibrin(ogen) cofactor, the Kmapp of the reaction with two-chain material decreases. With one-chain (R275E) material in the presence of the cofactor, the Kmapp also decreases to a similar value and in addition the kcatapp is increased, such that the kinetic constants become indistinguishable from those obtained with wild-type one- or two-chain material. © 1990.
引用
收藏
页码:527 / 539
页数:13
相关论文
共 40 条
[1]   INACTIVE PROENZYME TO TISSUE-TYPE PLASMINOGEN-ACTIVATOR FROM HUMAN-MELANOMA CELLS, IDENTIFIED AFTER AFFINITY PURIFICATION WITH A MONOCLONAL-ANTIBODY [J].
ANDREASEN, PA ;
NIELSEN, LS ;
GRONDAHLHANSEN, J ;
SKRIVER, L ;
ZEUTHEN, J ;
STEPHENS, RW ;
DANO, K .
EMBO JOURNAL, 1984, 3 (01) :51-56
[2]   DIFFERENT INHIBITION OF ONE AND TWO CHAIN TISSUE PLASMINOGEN-ACTIVATOR BY A PLACENTAL INHIBITOR STUDIED WITH 2 TRIPEPTIDE-PARA-NITROANILIDE SUBSTRATES [J].
ASTEDT, B ;
BLADH, B ;
CHRISTENSEN, U ;
LECANDER, I .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1985, 45 (05) :429-435
[3]   QUANTITATIVE CHARACTERIZATION OF THE BINDING OF PLASMINOGEN TO INTACT FIBRIN CLOTS, LYSINE-SEPHAROSE, AND FIBRIN CLEAVED BY PLASMIN [J].
BOK, RA ;
MANGEL, WF .
BIOCHEMISTRY, 1985, 24 (13) :3279-3286
[4]   THE SINGLE-CHAIN FORM OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR HAS CATALYTIC ACTIVITY - STUDIES WITH A MUTANT ENZYME THAT LACKS THE CLEAVAGE SITE [J].
BOOSE, JA ;
KUISMANEN, E ;
GERARD, R ;
SAMBROOK, J ;
GETHING, MJ .
BIOCHEMISTRY, 1989, 28 (02) :635-643
[5]   THE DETERMINATION OF RECOMBINANT HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR ACTIVITY BY TURBIDIMETRY USING A MICROCENTRIFUGAL ANALYZER [J].
CARLSON, RH ;
GARNICK, RL ;
JONES, AJS ;
MEUNIER, AM .
ANALYTICAL BIOCHEMISTRY, 1988, 168 (02) :428-435
[6]   CONSTRUCTION AND CHARACTERIZATION OF AN ACTIVE FACTOR-VIII VARIANT LACKING THE CENTRAL 1/3 OF THE MOLECULE [J].
EATON, DL ;
WOOD, WI ;
EATON, D ;
HASS, PE ;
HOLLINGSHEAD, P ;
WION, K ;
MATHER, J ;
LAWN, RM ;
VEHAR, GA ;
GORMAN, C .
BIOCHEMISTRY, 1986, 25 (26) :8343-8347
[7]  
ELLIS V, 1987, J BIOL CHEM, V262, P14998
[8]  
GORMAN C, 1988, 0260148 EUR PAT OFF
[9]  
GORMAN CM, 1990, IN PRESS DNA PROTEIN